Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation.

BACKGROUND Several approaches are available for evaluating heterogeneity in meta-analysis. Sensitivity analyses are often used, but these are often implemented in various non-standardized ways. METHODS We developed and implemented sequential and combinatorial algorithms that evaluate the change in between-study heterogeneity as one or more studies are excluded from the calculations. The algorithms exclude studies aiming to achieve either the maximum or the minimum final I(2) below a desired pre-set threshold. We applied these algorithms in databases of meta-analyses of binary outcome and >/=4 studies from Cochrane Database of Systematic Reviews (Issue 4, 2005, n = 1011) and meta-analyses of genetic associations (n = 50). Two I(2) thresholds were used (50% and 25%). RESULTS Both algorithms have succeeded in achieving the pre-specified final I(2) thresholds. Differences in the number of excluded studies varied from 0% to 6% depending on the database and the heterogeneity threshold, while it was common to exclude different specific studies. Among meta-analyses with initial I(2) > 50%, in the large majority [19 (90.5%) and 208 (85.9%) in genetic and Cochrane meta-analyses, respectively] exclusion of one or two studies sufficed to decrease I(2) < 50%. Similarly, among meta-analyses with initial I(2) > 25%, in most cases [16 (57.1%) and 382 (81.3%), respectively) exclusion of one or two studies sufficed to decrease heterogeneity even <25%. The number of excluded studies correlated modestly with initial estimated I(2) (correlation coefficients 0.52-0.68 depending on algorithm used). CONCLUSIONS The proposed algorithms can be routinely applied in meta-analyses as standardized sensitivity analyses for heterogeneity. Caution is needed evaluating post hoc which specific studies are responsible for the heterogeneity.

[1]  D. Petitti,et al.  Approaches to heterogeneity in meta‐analysis , 2001, Statistics in medicine.

[2]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[3]  Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. , 2000, The Cochrane database of systematic reviews.

[4]  Julian P T Higgins,et al.  Controlling the risk of spurious findings from meta‐regression , 2004, Statistics in medicine.

[5]  Alex J. Sutton,et al.  Methods for Meta-Analysis in Medical Research , 2000 .

[6]  David R. Jones,et al.  Methods for Exploring Heterogeneity in Meta-Analysis , 2001 .

[7]  Patricia Duhart McNair,et al.  Controlling risk , 2001, UBIQ.

[8]  F. Faggiano,et al.  Methadone maintenance at different dosages for opioid dependence. , 2003, The Cochrane database of systematic reviews.

[9]  D. Ghersi,et al.  Taxane containing regimens for metastatic breast cancer. , 2003, The Cochrane database of systematic reviews.

[10]  I Olkin,et al.  Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. , 2000, Statistics in medicine.

[11]  Thomas A Trikalinos,et al.  Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. , 2006, American journal of epidemiology.

[12]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[13]  Mark C Simmonds,et al.  Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.

[14]  S G Thompson,et al.  Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.

[15]  S. Thompson,et al.  Detecting and describing heterogeneity in meta-analysis. , 1998, Statistics in medicine.

[16]  A. Hrõbjartsson,et al.  Somatostatin analogues for acute bleeding oesophageal varices. , 2005, Cochrane Database of Systematic Reviews.

[17]  I. Roberts,et al.  Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. , 2001, The Cochrane database of systematic reviews.

[18]  P C Lambert,et al.  A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.

[19]  Edward C. Pickering,et al.  The graphical method , 1871 .

[20]  P. Glasziou,et al.  Investigating causes of heterogeneity in systematic reviews , 2002, Statistics in medicine.

[21]  Douglas G. Altman,et al.  Systematic Reviews in Health Care , 2001 .

[22]  Nikolaos A Patsopoulos,et al.  Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.

[23]  Douglas G. Altman,et al.  Systematic reviews in health care : meta-analysis in context , 2008 .

[24]  Harold I Feldman,et al.  Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head , 2002, Statistics in medicine.

[25]  Douglas G Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[26]  Tania B. Huedo-Medina,et al.  Assessing heterogeneity in meta-analysis: Q statistic or I2 index? , 2006, Psychological methods.

[27]  R F Galbraith,et al.  A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.

[28]  W. G. Cochran The combination of estimates from different experiments. , 1954 .

[29]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[30]  Paul Landais,et al.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. , 2004, Journal of clinical epidemiology.

[31]  Christopher H Schmid,et al.  Summing up evidence: one answer is not always enough , 1998, The Lancet.

[32]  Bertrand Baujat,et al.  A graphical method for exploring heterogeneity in meta‐analyses: application to a meta‐analysis of 65 trials , 2002, Statistics in medicine.